RecruitingNot applicableNCT06399822
Impact of Capillaroscopy on the Management of Undifferentiated Connective Tissue Disease
Studying OBSOLETE: Unclassified overlapping connective tissue disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- CHU de Quebec-Universite Laval
- Principal Investigator
- Laetitia Michou, MD PhDCHU de Quebec (Université Laval)
- Intervention
- Nail capillaroscopy(diagnostic_test)
- Enrollment
- 40 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2024 – 2027
Study locations (1)
- CHU de Quebec-Université Laval, Québec, Quebec, Canada
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06399822 on ClinicalTrials.govOther trials for OBSOLETE: Unclassified overlapping connective tissue disease
Additional recruiting or active studies for the same condition.
See all trials for OBSOLETE: Unclassified overlapping connective tissue disease →